S&P 500 Companies by Revenue vs Market Cap, Ranked

Which S&P 500 Companies Have the Highest Revenue in 2024?

The S&P 500's revenue leaders and its market cap leaders are almost entirely different lists. Walmart generated over $640 billion in fiscal 2024 revenue yet carries a market cap roughly one-sixth the size of Apple, which produced around $380 billion in revenue. That gap is the entire story of how modern equity markets price businesses.

For investors managing $5M+ portfolios, this divergence is not a curiosity. It has direct implications for how concentrated your passive index exposure actually is, how you think about sector rotation in a taxable account, and whether your "diversified" S&P 500 allocation is doing what you think it is.

The Revenue Leaders: Top S&P 500 Companies by Revenue

The companies that top the S&P 500 by revenue are not the ones dominating financial headlines. They are retailers, energy majors, and healthcare conglomerates operating on thin margins at massive scale.

According to Fortune's 2024 rankings, Walmart remains the largest U.S. company by revenue, exceeding $640 billion in annual sales. Amazon, ExxonMobil, Apple, and UnitedHealth Group round out the top tier. These are businesses processing enormous transaction volumes, but the market prices them accordingly: low multiples, modest growth expectations, and in several cases, meaningful dividend yields.

The table below shows where revenue rank and market cap rank diverge most sharply, which is where the analytical value lives.

Figures are approximate based on most recently reported fiscal year data. Market caps fluctuate daily.

The price-to-sales spread between Nvidia (roughly 25x) and CVS Health (roughly 0.2x) is not irrational. It reflects margin trajectory, competitive moat, and growth optionality. But it does mean these companies require entirely different analytical frameworks.

What Is the Difference Between Revenue Ranking and Market Cap Ranking?

The short answer: revenue measures what a company does today, and market cap measures what investors expect it to do tomorrow.

According to S&P Global's index methodology, the S&P 500 uses float-adjusted market capitalization weighting. The largest companies by market cap exert disproportionate influence on index returns, regardless of their revenue rank. A company generating $640 billion in sales but trading at 0.8x revenue has far less index weight than a company generating $80 billion in sales but trading at 25x revenue.

This is why the top companies by revenue and the top companies by index weight are almost entirely different lists.

The market prices margin trajectory, not revenue scale. According to S&P Global data, the S&P 500's aggregate net profit margin has historically ranged from 8% to 13%. Technology sector margins frequently run 20-30%+, while retail and energy margins often sit at 1-5%. The market is not ignoring Walmart's $640 billion in revenue. It is correctly observing that Walmart keeps roughly $15 billion of it.

For a FATFIRE investor, this distinction matters when evaluating factor tilts. An equal-weight S&P 500 strategy gives Walmart and Nvidia the same allocation. A cap-weighted strategy gives Nvidia roughly 6x the weight of Walmart. Neither is wrong, but they are very different bets on how the margin gap evolves.

How Does Concentration in Top S&P 500 Companies Affect Portfolio Risk?

This is the question most retail-oriented commentary ignores entirely.

According to Schwab Center for Financial Research, the top 10 S&P 500 companies by market capitalization have at times represented over 30% of the entire index weight. As of 2024, Apple, Microsoft, Nvidia, Amazon, and Alphabet collectively account for approximately 32-35% of the index. These five companies alone represent more index weight than the bottom 350 companies combined.

For a $10M equity allocation to an S&P 500 index fund, that means roughly $3.2-3.5M is concentrated in five names. If you also hold any of these companies directly, through RSUs, through a concentrated position inherited or built over time, or through sector-specific ETFs, your actual exposure is likely higher than your allocation statement suggests.

The Journal of Financial Planning has documented that high-net-worth investors face amplified concentration risk when large-cap equity holdings overlap with employer stock or private business exposure in the same sectors. A founder who built a software company and holds S&P 500 index funds is more concentrated in technology than the index weight alone implies.

Practical steps worth reviewing with your advisor:

• Map your total technology sector exposure across all accounts, including private holdings
• Assess whether your S&P 500 allocation is genuinely diversifying or doubling down on existing sector bets
• Consider equal-weight or revenue-weighted alternatives if cap-weight concentration conflicts with your risk framework

The S&P 500 versus total market comparison is also relevant here: total market funds add small- and mid-cap exposure that partially dilutes mega-cap concentration.

Which S&P 500 Sectors Generate the Most Total Revenue?

Sector-level revenue analysis reveals a different picture than sector-level market cap analysis, and the gap between the two is where rotation opportunities and tax-efficient rebalancing decisions often originate.

Figures are approximate and shift with market conditions and index rebalancing.

Energy and healthcare sectors generate enormous aggregate revenues but trade at price-to-sales multiples of 0.3x to 1.5x, according to Morningstar's sector valuation analysis. Technology companies frequently trade above 10x revenue. That gap has historically narrowed during inflationary periods and widened during low-rate growth environments.

For sector performance trends over time, the rotation pattern is consistent: when rates rise and growth multiples compress, revenue-heavy, low-multiple sectors outperform. When rates fall and growth re-rates upward, the inverse holds.

How Do Price-to-Sales Ratios Vary Across S&P 500 Revenue Leaders?

The price-to-sales ratio is an underused tool for sophisticated investors precisely because it strips out the earnings manipulation that P/E ratios are vulnerable to. A company can manage earnings through depreciation schedules, buybacks, and one-time charges. Revenue is harder to obscure.

Reviewing historical PE ratio valuations alongside price-to-sales data gives a more complete picture of where valuation risk is concentrated at any given time.

The practical application for large taxable accounts: when a sector's P/S ratio expands significantly above its historical range, the embedded gain in those positions is likely substantial. That creates a tax-timing decision. Harvesting losses in overvalued growth positions during corrections while rotating into revenue-heavy, lower-multiple sectors can accomplish two things simultaneously: it resets your cost basis and repositions toward sectors with more valuation support, without requiring you to exit equities entirely.

IRS Publication 550 governs the wash-sale rules that constrain this kind of harvesting. The 30-day rule applies to substantially identical securities, but rotating from a technology-heavy growth ETF into an energy or healthcare sector fund does not trigger wash-sale treatment, provided the positions are genuinely distinct.

The earnings per share metrics for revenue leaders versus market cap leaders also diverge in instructive ways. Walmart's EPS is modest relative to its revenue because margins are thin. Microsoft's EPS is substantial relative to its revenue because margins are not.

How Do S&P 500 Revenue Leaders Compare to Their Stock Performance?

The honest answer: revenue leadership does not predict stock performance, and the historical record is clear on this.

Vanguard's research demonstrates that market-cap-weighted index funds outperform most actively managed strategies over long time horizons. Part of the reason is that active managers frequently overweight revenue leaders on the assumption that large, stable revenue bases translate to stable returns. They often do not.

ExxonMobil and Chevron have ranked among the top S&P 500 revenue generators for decades. Their 10-year performance analysis versus the broader index shows extended periods of significant underperformance, particularly during the 2014-2020 oil price downturn. Revenue scale did not protect shareholders.

Conversely, Nvidia ranked well outside the top 20 S&P 500 companies by revenue as recently as 2022. Its stock performance over the subsequent two years was among the strongest in the index's history.

The implication is not that revenue is irrelevant. It is that revenue rank, in isolation, is a poor predictor of forward returns. What matters is the relationship between current revenue, margin trajectory, and the multiple the market is already pricing in. A company growing revenue at 20% annually and trading at 5x sales is a different proposition than one growing at 5% and trading at 20x sales, even if their absolute revenue figures are similar.

For historical S&P 500 returns context, the index's long-run appreciation has been driven far more by multiple expansion and margin improvement than by revenue growth alone.

Should High-Net-Worth Investors Overweight S&P 500 Revenue Leaders?

The case for overweighting revenue leaders rests on valuation discipline: low P/S multiples, tangible cash flows, and dividend income that does not depend on multiple expansion to generate returns.

The case against: revenue leaders in mature, low-margin industries often face structural headwinds. Retail faces ongoing margin pressure from e-commerce competition. Energy faces long-term demand uncertainty from the energy transition. Healthcare faces persistent regulatory and reimbursement risk.

The more useful framing for a FATFIRE investor is not whether to overweight revenue leaders categorically, but whether the current valuation spread between revenue leaders and market cap leaders is at an extreme that warrants a tactical tilt.

When technology P/S ratios are running 15-20x above energy and retail P/S ratios, as they have during extended low-rate periods, the margin of safety in revenue-heavy sectors is meaningfully higher. When that spread compresses, as it did during 2022's rate-driven correction, the relative advantage diminishes.

Assessing fair market value at the sector level, rather than the individual stock level, is a more tractable exercise for most investors and one that maps more cleanly onto tax-efficient rebalancing decisions.

A few structural considerations worth discussing with your tax attorney:

• Revenue-heavy, low-multiple stocks tend to generate more dividend income and less capital appreciation, which affects after-tax return calculations for investors in the top ordinary income bracket
• Dividend distribution patterns across revenue leaders show more consistency than among growth-oriented market cap leaders, which matters for investors funding lifestyle expenses from portfolio distributions
• Equal-weight or revenue-weighted factor strategies can reduce mega-cap concentration without requiring active stock selection

Understanding the Criteria That Shape the Revenue Landscape

The criteria for index inclusion set a floor on company quality and liquidity, but they do not guarantee that index constituents represent the best risk-adjusted opportunities at any given time. The S&P 500 is a rules-based index, not a curated portfolio.

S&P Global's methodology requires, among other criteria, positive as-reported earnings over the most recent four quarters, a minimum float-adjusted market cap, and adequate liquidity. Revenue is not a direct inclusion criterion. A company can enter the index with modest revenues if its market cap qualifies, and a company with enormous revenues can be excluded if it fails the earnings or float requirements.

This matters because the revenue distribution within the index is partly an artifact of which high-revenue businesses happen to be publicly traded and meet the inclusion criteria. McKesson, a pharmaceutical distributor generating over $300 billion in annual revenue, qualifies. Many similarly large private businesses do not appear in the data at all.

For investors trying to use S&P 500 revenue analysis as a proxy for the broader economy, this selection bias is worth keeping in mind. The FRED database tracks aggregate S&P 500 revenues and earnings over time, and the Federal Reserve Bank of St. Louis data illustrates the long-run relationship between corporate revenue growth and equity index appreciation, but the index is not a complete sample of U.S. corporate revenue.

Practical Portfolio Construction Using Revenue and Valuation Data

The analytical framework that actually moves the needle for large portfolios combines three inputs: revenue growth rate, current P/S ratio relative to sector history, and after-tax return implications given your specific cost basis situation.

A simplified version of the decision matrix:

The distinction between "value with catalyst" and "value trap" is where the analysis gets genuinely hard. CVS Health trades at roughly 0.2x revenue. That is either a deep value opportunity or a reflection of structural deterioration in its pharmacy and insurance businesses. Revenue scale alone does not answer that question.

What it does do is give you a starting point for position sizing. A stock trading at 0.2x revenue has a different downside profile than one trading at 25x revenue, all else equal. For a $10M+ equity portfolio, that asymmetry is worth building into your sector allocation framework explicitly rather than accepting whatever the cap-weighted index delivers.

Combining this analysis with assessing fair market value at the index level and reviewing sector performance trends over full market cycles gives a more complete picture than any single metric provides on its own.

References

• S&P Global -- "S&P 500 Index Methodology" (2024)
• Fortune -- "Fortune 500 Annual Rankings" (2024)
• Morningstar -- "U.S. Stock Market Valuation and Sector Analysis" (2024)
• Federal Reserve Bank of St. Louis (FRED) -- "S&P 500 Earnings and Revenue Data" (2024)
• Vanguard -- "Vanguard's Principles for Investing Success" (2023)
• Journal of Financial Planning -- "Concentration Risk and Portfolio Construction for High-Net-Worth Investors" (2022)
• IRS -- "Publication 550: Investment Income and Expenses" (2023)
• Schwab Center for Financial Research -- "Does Market Cap Weighting Still Make Sense?" (2023)